Thai anti-Covid nasal spray ready for commercial saleThe press conference at Samyan Mitrtown Hall where a team of doctors and researchers introduced an anti-Covid nasal spray produced for commercial sale. (Photo: Apichart Jinakul)A nasal spray to prevent Covid-19 infection developed by Thai medical researchers will be available for commercial sale from Oct 1, Worawan Chaikamnerd, chief executive officer of Hibiocy Co and Rojukiss International Public Company Ltd announced on Monday. Ms Worawan said it would be sold under the brandname "VAILL COVITRAP Anti-Cov Nasal Spray" and was produced by Hibiocy Co, a subsidiary of Rojukiss International. Developed by a team of doctors and researchers from the faculty of medicine, Chulalongkorn University, the spray is truly a Thai innovation for Thai people, she said. VAILL COVITRAP Anti-Cov Nasal Spray will be available for commercial sale from Oct 1.
